Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
EVFM US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Evofem Biosciences, Inc.
(EVFM US)
$0.01
+0.00
6.90%
(Market Open · 20:50:22 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
EVFM US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Evofem Biosciences, Inc.
(EVFM US)
$0.01
+0.00
6.90%
(Market Open · 20:50:22 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological SEC Filings
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(449)
Expand
8-K
Results of Operations and Financial Condition
04:59PM
10-Q
Q3
ended 30 Sept 2026
04:57PM
8-K
Entry into a Material Definitive Agreement
15 Oct
8-K
Entry into a Material Definitive Agreement
23 Sep
10-Q
Q2
ended 30 Jun 2026
14 Aug
8-K
Regulation FD Disclosure
20 Jul
8-K
Entry into a Material Definitive Agreement
14 Jul
8-K
Results of Operations and Financial Condition
18 May
10-Q
Q1
ended 31 Mar 2026
15 May
8-K
Entry into a Material Definitive Agreement
30 Apr
8-K
Entry into a Material Definitive Agreement
16 Apr
8-K
Termination of a Material Definitive Agreement
19 Mar
8-K
Results of Operations and Financial Condition
11 Mar
10-K
FY 2025
ended 31 Dec 2025
11 Mar
8-K
Regulation FD Disclosure
12 Jan
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
26 Nov 2025
8-K
Results of Operations and Financial Condition
13 Nov 2025
10-Q
Q3
ended 30 Sept 2025
13 Nov 2025
DEF 14A
Definitive proxy statement
29 Oct 2025
8-K
Termination of Material Agreement
20 Oct 2025
Ownership Filings
(337)
Expand
SC 13D
Evofem Biosciences, Inc.
4 Aug
SC 13G/A
Evofem Biosciences, Inc.
14 Feb 2024
Form 4
Zhang Yan
12 Jan 2024
Form 4
Kamdar Kim P.
22 Dec 2023
Form 5
File Justin J.
8 May 2023
Form 3
Zhang Yan
26 Apr 2023
Form 4
PELLETIER SAUNDRA L
26 Apr 2023
SC 13G/A
Evofem Biosciences, Inc.
14 Feb 2023
SC 13G/A
Evofem Biosciences, Inc.
10 Aug 2022
Form 3
Yip Jenny C.
8 Aug 2022
SC 13G
Evofem Biosciences, Inc.
19 Jul 2022
Form 3
Atkinson Katherine Cocca
7 Jun 2022
Form 4
PELLETIER SAUNDRA L
31 May 2022
Form 4
O'Brien Anthony Stephen
6 May 2022
Form 4
Kamdar Kim P.
6 May 2022
Form 4
Rarick Lisa Dale
6 May 2022
Form 4
Rutherford Colin
6 May 2022
Form 4
Greer Gillian
6 May 2022
Form 4
Fitzpatrick Alexander A
23 Feb 2022
Form 4
PELLETIER SAUNDRA L
23 Feb 2022
Select Filings
Non-Ownership Filings
(449)
Expand
8-K
Results of Operations and Financial Condition
04:59PM
10-Q
Q3
ended 30 Sept 2026
04:57PM
8-K
Entry into a Material Definitive Agreement
15 Oct
8-K
Entry into a Material Definitive Agreement
23 Sep
10-Q
Q2
ended 30 Jun 2026
14 Aug
8-K
Regulation FD Disclosure
20 Jul
8-K
Entry into a Material Definitive Agreement
14 Jul
8-K
Results of Operations and Financial Condition
18 May
10-Q
Q1
ended 31 Mar 2026
15 May
8-K
Entry into a Material Definitive Agreement
30 Apr
8-K
Entry into a Material Definitive Agreement
16 Apr
8-K
Termination of a Material Definitive Agreement
19 Mar
8-K
Results of Operations and Financial Condition
11 Mar
10-K
FY 2025
ended 31 Dec 2025
11 Mar
8-K
Regulation FD Disclosure
12 Jan
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
26 Nov 2025
8-K
Results of Operations and Financial Condition
13 Nov 2025
10-Q
Q3
ended 30 Sept 2025
13 Nov 2025
DEF 14A
Definitive proxy statement
29 Oct 2025
8-K
Termination of Material Agreement
20 Oct 2025
Ownership Filings
(337)
Expand
SC 13D
Evofem Biosciences, Inc.
4 Aug
SC 13G/A
Evofem Biosciences, Inc.
14 Feb 2024
Form 4
Zhang Yan
12 Jan 2024
Form 4
Kamdar Kim P.
22 Dec 2023
Form 5
File Justin J.
8 May 2023
Form 3
Zhang Yan
26 Apr 2023
Form 4
PELLETIER SAUNDRA L
26 Apr 2023
SC 13G/A
Evofem Biosciences, Inc.
14 Feb 2023
SC 13G/A
Evofem Biosciences, Inc.
10 Aug 2022
Form 3
Yip Jenny C.
8 Aug 2022
SC 13G
Evofem Biosciences, Inc.
19 Jul 2022
Form 3
Atkinson Katherine Cocca
7 Jun 2022
Form 4
PELLETIER SAUNDRA L
31 May 2022
Form 4
O'Brien Anthony Stephen
6 May 2022
Form 4
Kamdar Kim P.
6 May 2022
Form 4
Rarick Lisa Dale
6 May 2022
Form 4
Rutherford Colin
6 May 2022
Form 4
Greer Gillian
6 May 2022
Form 4
Fitzpatrick Alexander A
23 Feb 2022
Form 4
PELLETIER SAUNDRA L
23 Feb 2022
Ask in Filing
Ask in Filing
